Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  The Lancet Diabetes and Endocrinology

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S2213-8587(14)70088-9PMID 24831989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

  2013cited by this paper
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

  2013cited by this paper
• Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study

  2013cited by this paper
• Basal insulin and cardiovascular and other outcomes in dysglycemia.

  2012cited by this paper
• Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

  2011cited by this paper
• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

  2010cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Intensive glucose control and macrovascular outcomes in type 2 diabetes

  2009cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

  2006cited by this paper
• The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.

  2006cited by this paper
• Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

  2005cited by this paper
• Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis.

  2004cited by this paper
• The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

  2001cited by this paper
• Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper
• Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper

• Impact of Hyperglycemia on Complication and Mortality after Transarterial Chemoembolization for Hepatocellular Carcinoma

  2024cites this paper
• Causal association of metformin treatment with diverse cardiovascular diseases: a Mendelian randomization analysis

  2024cites this paper
• Stress, Hyperglycemia, and Insulin Resistance Correlate With Neutrophil Activity and Impact Acute Myocardial Infarction Outcomes

  2024cites this paper
• In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation

  2024cites this paper
• Prospects for the convergence of polyphenols with pharmaceutical drugs in Type 2 Diabetes: challenges, risks, and strategies.

  2024cites this paper
• Effects of tranexamic acid preconditioning on the incidence of postpartum haemorrhage in vaginal deliveries with identified risk factors in China: a prospective, randomized, open-label, blinded endpoint trial

  2024cites this paper
• 2023 ESC Guidelines for the management of acute coronary syndromes.

  2023cites this paper
• Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease

  2023cites this paper
• Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients

  2023cites this paper
• Fibrinogen-to-Albumin Ratio and Long-Term Mortality in Coronary Artery Disease Patients with Different Glucose Metabolism Status

  2023influential citation
• 2023 ESC Guidelines for the management of acute coronary syndromes.

  2023cites this paper
• Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes

  2023cites this paper
• Protective Factors and the Pathogenesis of Complications in Diabetes

  2023cites this paper
• Stress hyperglycemia ratio and long‐term prognosis in patients with acute coronary syndrome: A multicenter, nationwide study

  2023cites this paper
• Treatment of type 2 diabetes patients with heart conditions

  2023cites this paper
• HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease

  2023cites this paper
• Effect of Intensive Glycemic Control on Myocardial Infarction Outcome in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

  2023cites this paper
• Management of Type 2 Diabetes in Acute Coronary Syndromes: Current State and Future Perspectives.

  2023cites this paper
• Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study

  2022cites this paper
• Approccio diagnostico e terapeutico al paziente con sindrome coronarica acuta

  2022cites this paper
• Real-world evaluation of glucose-lowering therapies and the use of weight-adjusted variable rate intravenous insulin infusion in the management of hyperglycaemia in patients with acute coronary syndrome (REGULATE-ACS).

  2022cites this paper
• Associations of BMI with mortality in HFpEF patients with concomitant diabetes with insulin versus non-insulin treatment.

  2022cites this paper
• Association of admission hyperglycemia and all-cause mortality in acute myocardial infarction with percutaneous coronary intervention: A dose–response meta-analysis

  2022cites this paper
• Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection

  2022cites this paper
• Contemporary Medical Therapies for Patients with Peripheral Artery Disease and Concomitant Type 2 Diabetes Mellitus: a Review of Current Evidence

  2022cites this paper
• HEALTH CONDITIONS AND TEMPORAL STABILITY OF THE INTERNAL STRUCTURE OF ILLNESS REPRESENTATION IN PATIENTS WITH MYOCARDIAL INFARCTION

  2022cites this paper
• Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy

  2021cites this paper
• MG53 E3 Ligase-dead Mutant Protects Diabetic Hearts from Acute Ischemic/Reperfusion Injury and Ameliorates Diet-induced Cardiometabolic Damage.

  2021cites this paper
• Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)

  2021cites this paper
• Role of glucagon-like peptide-1 agonist in patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: A meta-analysis

  2021cites this paper
• Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST

  2021cites this paper
• ЕВРАЗИЙСКИЕ РЕКОМЕНДАЦИИ ПО ПРОФИЛАКТИКЕ И ЛЕЧЕНИЮ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У БОЛЬНЫХ С ДИАБЕТОМ И ПРЕДИАБЕТОМ (2021)

  2021cites this paper
• Insulin Therapy Is Associated With an Increased Risk of Carotid Plaque in Type 2 Diabetes: A Real-World Study

  2021cites this paper
• Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives

  2021cites this paper
• Insulintherapie bei Diabetes mellitus Typ 2: patientenzentriert, rechtzeitig, nutzen-risiko-bilanziert; Standortbestimmung 2019 nach dem ADA/EASD-Konsensus 2018

  2020cites this paper
• Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction

  2020cites this paper
• Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V

  2020cites this paper
• 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  2020cites this paper
• The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction

  2020cites this paper
• Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update

  2020cites this paper
• Effectiveness of glucose-insulin–potassium infusion for myocardial protection in non-diabetic patients during adult cardiac surgery

  2020cites this paper
• Long-Term Impact of Diabetes Mellitus on Initially Conservatively Managed Patients With Severe Aortic Stenosis.

  2020cites this paper
• Admission glucose level was associated with increased short-term mortality and length-of-stay irrespective of diagnosis, treating medical specialty or concomitant laboratory values.

  2020cites this paper
• Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD)

  2020cites this paper
• From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents.

  2020cites this paper
• Differences of clinical and laboratory findings between diabetic and non-diabetic patients with st-elevation myocardial infarction

  2019cites this paper
• Diabetes and Mortality in Acute Coronary Syndrome: Findings from the Gulf COAST registry.

  2019cites this paper
• The Association Between Insulin Initiation and Adverse Outcomes After Hospital Discharge in Older Adults : a Population-Based Cohort Study

  2019cites this paper
• Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome

  2019cites this paper
• The Association Between Insulin Initiation and Adverse Outcomes After Hospital Discharge in Older Adults: a Population-Based Cohort Study

  2019cites this paper
• Association of Hyperglycemia and Final TIMI Flow with One-Year Mortality of Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI

  2019cites this paper
• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

  2019cites this paper
• Legacy Effect of Intensive Blood Glucose Control on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Very High Risk or Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials.

  2018cites this paper
• Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry Report

  2018cites this paper
• Insulin Therapy and Cardiovascular Outcome Trials (Cvots): Any Harm, Anytime?

  2018cites this paper
• Management of Diabetes and/or Hyperglycemia in Acute Coronary Syndrome, Acute Stroke, and Acute Heart Failure

  2018cites this paper
• Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes

  2018cites this paper
• The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis

  2018cites this paper
• Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets

  2018cites this paper
• Insulin therapy, weight gain and prognosis

  2018cites this paper
• Myocardial protection with Glucose-Insulin-Potassium infusion during adult cardiac surgery

  2017cites this paper
• Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade.

  2017cites this paper
• Protective effect of diethylcarbamazine inhibits NF-κB activation in isoproterenol-induced acute myocardial infarction rat model through the PARP pathway.

  2017cites this paper
• Long-term studies of treatments for type 2 diabetes

  2017cites this paper
• Quality of sleep and its determinants among people with type 2 diabetes mellitus in Northwest of Iran

  2017cites this paper
• Melatonin rescues cardiac thioredoxin system during ischemia‐reperfusion injury in acute hyperglycemic state by restoring Notch1/Hes1/Akt signaling in a membrane receptor‐dependent manner

  2017cites this paper
• Interventions in type 2 diabetes mellitus and cardiovascular mortality-An overview of clinical trials.

  2017cites this paper
• Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting

  2017cites this paper
• Protective effect of glucagon-like peptide-1 agents on reperfusion injury for acute myocardial infarction: a meta-analysis of randomized controlled trials

  2017cites this paper
• Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes.

  2017cites this paper
• Issues in achieving glycemic goals The role of HbA 1 c Antihyperglycemic drugs and cardiovascular outcomes Newer oral and noninsulin therapies New insulin preparations Inpatient hyperglycemia management

  2016cites this paper
• Glycemia control and glucose-lowering therapy in patients with type 2 diabetes mellitus and cardiovascular disease (review of multicenter randomized trials)

  2016cites this paper
• No benefit of additional treatment with exenatide in patients with an acute myocardial infarction.

  2016cites this paper
• Antihyperglycemic drugs and cardiovascular outcomes in type 2 diabetes

  2016cites this paper
• A single-centre cohort study of National Early Warning Score (NEWS) and near patient testing in acute medical admissions.

  2016cites this paper
• Summary of new evidence Adults with acute coronary syndromes and hyperglycaemia with a diagnosis of diabetes

  2016cites this paper
• Surveillance report 2016 – Hyperglycaemia in acute coronary syndromes National Institute for Health and Care Excellence Surveillance programme Surveillance proposal consultation document Hyperglycaemia in acute coronary syndromes NICE CG130 – 4-year surveillance review Background information

  2016cites this paper
• Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice

  2016cites this paper
• Lessons learned from cardiovascular outcome clinical trials with dipeptidyl peptidase 4 (DPP-4) inhibitors

  2016cites this paper
• A study of the descriptive epidemiology and clinical effectiveness of treatment for type 2 diabetes using routine general practice data

  2015cites this paper
• Mechanisms of hypoglycaemia related sudden cardiac death in type 2 diabetes mellitus

  2015cites this paper
• Glucose management in critically ill adults and children.

  2015cites this paper
• Endocrine and metabolic considerations in critically ill patients 1 Glucose management in critically ill adults and children

  2015cites this paper
• Clinical trials comparing basal insulins Glargine versus NPH

  2015cites this paper
• WITHDRAWN: Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

  2015cites this paper
• High Event Rate After a First Percutaneous Coronary Intervention in Patients With Diabetes Mellitus: Results From the Swedish Coronary Angiography and Angioplasty Registry

  2015cites this paper
• ACUTE MYOCARDIAL INFARCTION AND AFFECTIVE SPECTRUM DISORDERS

  2015cites this paper
• Diabetes: Glycaemia and insulin after acute myocardial infarction

  2014cites this paper
• DIGAMI 1: 20 years later.

  2014cites this paper
• The clinical burden of type 2 diabetes in patients with acute coronary syndromes: Prognosis and implications for short- and long-term management

  2014cites this paper
• efforts to translate diabetes cardiovascular outcome trials into clinical practice

  year unknowncites this paper
• Drug, Healthcare and Patient Safety Dovepress Cardiovascular Effects of Basal Insulins

  year unknowncites this paper